🇺🇸 FDA
Patent

US 8119590

Prevention and treatment of restenosis by local administration of drug

granted A61KA61K38/17A61P

Quick answer

US patent 8119590 (Prevention and treatment of restenosis by local administration of drug) held by Esperion Therapeutics, Inc. expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K38/17, A61P, A61P9/00, A61P9/10